Practice Update: Cardiology

3 / 24

PracticeUpdate Cardiology is
published by Elsevier Australia
ISSN 2206-4672 (Print) ISSN 2208-0228 (Online)
ABN 70 001 002 357
475 Victoria Avenue
Chatswood NSW 2067 Australia
Locked Bag 7500 Chatswood DC NSW 2067
EMCN061701
PracticeUpdate is guided by a world-renowned
Editorial and Advisory Board that represents
community practitioners and academic specialists
with cross-disciplinary expertise.
Editor-in-Chief Douglas Zipes MD
Associate Editors Joerg Herrmann MD,
Benjamin Scirica MD
Advisory Board
Deepak Bhatt MDMPH FACC FAHA FSCAI FESC,
Peter Libby MD, Paul Thompson MD,
James Udelson MD, Ronald Victor MD, Gary Webb MD,
Clyde Yancy MDMScMACCFAHAMACP FHFSA
Editorial Contributors Ashish Aggarwal
MD, Samer Ajam MD, Jason Garlie MD
PracticeUpdate® is a registered trademark of Elsevier
Inc. © 2017 Elsevier Inc. All rights reserved.
ABOUT
PracticeUpdate Cardiologyprovides coverage of key
research from leading international conferences, and
a collection of top journal articles and accompanying
expert commentaries in a convenient print periodical.
These and more are also available online at www.
PracticeUpdate and PracticeUpdate Cardiology
are commercially supported by advertising,
sponsorship, and educational grants. Individual access
to is free. Premium content is
available to any user who registers with the site.
While PracticeUpdate is a commercially-sponsored
product, it maintains the highest level of academic
rigour, objectivity, and fair balance associated with all
Elsevier products. No editorial content is influenced
in any way by commercial sponsors or content
contributors.
DISCLAIMER
PracticeUpdate Cardiology has been developed
for specialist medical professionals. The ideas
and opinions expressed in this publication do not
necessarily reflect those of the Publisher. Elsevier will
not assume responsibility for damages, loss, or claims
of any kind arising from or related to the information
contained in this publication, including any claims
related to the products, drugs, or services mentioned
herein. Because of rapid advances in the medical
sciences, in particular, independent verification
of diagnoses and drug dosages should be made.
Please consult the full current Product Information
before prescribing any medication mentioned in this
publication.
Although all advertising material is expected to
conform to ethical (medical) standards, inclusion in
this publication does not constitute a guarantee or
endorsement of the quality or value of such product or
of the claims made of it by its manufacturer.
SALES
Fleur Gill
Linnea Mitchell-Taverner
PRODUCTION
Editorial Manager Anne Neilson
Editorial Project Manager Carolyn Ng
DesignerJana Sokolovskaja
Features
21
My approach
to the patient
with an infected
implantable
cardioverter
defibrillator (ICD)
22
My approach to
the patient with
left main disease
Conference coverage
8
ACC 2017
8 ACC expert roundups
10
ATS 2017
10 COPD exacerbations
in those with CVD may
raise MI/stroke risk
12 Sleep apnea may
increase risk of atrial
fibrillation
Cover
4
Sudden
cardiac death:
pharmacotherapy
and proarrhythmic
drugs
RESEARCH
Editor’s picks
4 Sudden cardiac death:
pharmacotherapy and
proarrhythmic drugs
5 GI safety of celecoxib vs
naproxen in patients with
cardiothrombotic diseases
and arthritis after upper GI
bleeding
6 Ambulatory hemodynamic
monitoring reduces heart
failure hospitalizations in
“real-world” clinical practice
7 Elderly patients cared for by
younger physicians have
lower mortality rates
7 Lower risk of heart failure
and death in patients initiated
on SGLT-2 inhibitors vs other
glucose-lowering drugs
Hypertension
13 Maternal antihypertensive use
and congenital heart defects
Arrhythmias/heart rhythm
disorders
14 Systemic inflammation
as a novel QT-prolonging
risk factor in patients with
Torsades de Pointes
15 Incidence of AF sinks following
normalization of testosterone
levels after testosterone
replacement therapy
Cardiac imaging
16 Acute kidney injury after radial
or femoral access for invasive
acute coronary syndrome
management
17 Effect of metformin and
lifestyle on coronary artery
calcium in the Diabetes
Prevention Program
Heart failure
18 Update on the management
of heart failure from the ACC/
AHA/HFSA
19 Risk assessment and
comparative effectiveness of
left ventricular assist device
and medical management
in ambulatory heart failure
patients
Interventional cardiology
20 Long-term outcomes improve
when patients are switched to
clopidogrel after ACS
CONTENTS 3
VOL. 2 • NO. 1 • 2017